Michel C, Matte-Tailliez O, Kerouault B, Bernardet J-F
Unité de Virologie et Immunologie Moléculaires, Institut National de la recherche Agronomique, Centre de Recherches de Jouy-en-Josas, Jouy-en-Josas, France.
J Appl Microbiol. 2005;99(2):323-32. doi: 10.1111/j.1365-2672.2005.02592.x.
To assess the susceptibility of Chryseobacterium isolates of fish and aquatic habitats to antimicrobial compounds. Special attention was paid to the resistance to chloramphenicol and florfenicol, a phenicol derivative recently licensed for use in veterinary medicine and fish farming.
Sixty-seven Chryseobacterium spp. isolates and reference strains, originating mainly from different aquatic habitats, were tested using the disk-diffusion method. In addition, agar dilution was used for assessing minimum inhibitory concentration of chloramphenicol and florfenicol. In spite of (i) conditions that hampered properly standardized experiments and (ii) the heterogeneity of the isolates resulting in some aberrant values in diffusion, correlation between the two methods was confirmed. Most of the isolates exhibited considerable multiresistance to most antimicrobial drug families, and many were clearly resistant to phenicols. Molecular investigations conducted on 10 strains selected for high resistance to florfenicol did not establish the existence of floR or cmlA genes currently reported in the literature as responsible for florfenicol resistance. Nevertheless, when an efflux pump inhibitor, phenyl-arginin-beta-naphthylamide, was combined with diffusion tests, drug susceptibility to florfenicol was restored, suggesting that Chryseobacterium's resistance to this molecule is under the control of efflux mechanisms.
Constitutive multiresistance to antibiotics is common in chryseobacteria isolated from the aquatic environment. Although no gene related to the floR family could be detected, efflux mechanisms could partly support the resistance to phenicols.
These results explain the difficulty of treatment and clearly reflect the properties previously reported in Chryseobacterium isolates of human origin. Because several species have been involved in opportunistic infections in humans, the possible role of aquatic organisms as a source of infection should be considered.
评估从鱼类和水生栖息地分离出的金黄杆菌对抗菌化合物的敏感性。特别关注了对氯霉素和氟苯尼考的耐药性,氟苯尼考是一种最近被批准用于兽医学和养鱼业的氯霉素衍生物。
使用纸片扩散法对主要来自不同水生栖息地的67株金黄杆菌属菌株和参考菌株进行了测试。此外,采用琼脂稀释法评估氯霉素和氟苯尼考的最低抑菌浓度。尽管(i)条件阻碍了实验的适当标准化,以及(ii)菌株的异质性导致扩散中出现一些异常值,但两种方法之间的相关性得到了证实。大多数菌株对大多数抗菌药物类别表现出相当程度的多重耐药性,许多菌株对氯霉素类明显耐药。对10株对氟苯尼考具有高耐药性的菌株进行的分子研究未发现目前文献中报道的负责氟苯尼考耐药性的floR或cmlA基因的存在。然而,当一种外排泵抑制剂苯基-精氨酸-β-萘酰胺与扩散试验联合使用时,对氟苯尼考的药物敏感性得以恢复,这表明金黄杆菌对该分子的耐药性受外排机制控制。
从水生环境分离出的金黄杆菌中,对抗生素的组成型多重耐药性很常见。尽管未检测到与floR家族相关的基因,但外排机制可能部分支持对氯霉素类的耐药性。
这些结果解释了治疗的困难,并清楚地反映了先前在源自人类的金黄杆菌分离株中报道的特性。由于几种金黄杆菌属物种已涉及人类机会性感染,应考虑水生生物作为感染源的可能作用。